Work

Genetic and expressional studies of Alzheimer's disease candidate genes, Emphasis on CYP19, seladin-1 and HSPG2 genes (Alzheimerin taudille altistavien ehdokasgeenien geneettisiä ja ilmentymistutkimuksia painottuen CYP19, Seladiini-1 ja HSPG2 geeneihin)

Year: 2005
Type: dissertation
Study design: Observational Study
Abstract: The aging of the population as result of elongated life expectancy will increase also the number of individuals affected by dementing disorders leading to loss of independence and ability to cope with the problems of everyday life.Alzheimer's disease (AD) is the most common form of dementia, affecting up to 20 % of population aged over 90 years.Most AD cases take place in late life, but a minority is affected as early as the age of 30 years, these being termed early-onset AD cases.These rare cases are often attributable to autosomal dominant mutations in the amyloid precursor protein (APP) and presenilin (PSEN) 1 and 2 genes that cause the earlier onset of symptoms like memory loss and confusion and neuropathological changes including neuronal loss, intracellular neurofibrillary tangles and extracellular amyloid deposits.Nonetheless, the mystery behind a substantial amount of AD cases, i.e. the late-onset cases, remains unsolved, since the only widely established susceptibility gene, the APOE, accounts for only approximately half of the late-onset AD cases.In the present series of studies, the objective was to identify new susceptibility loci for late-onset AD and to study their expressional changes in AD or in AD models using molecular biological approaches such as single nucleotide polymorphisms and reverse transcription polymerase chain reaction methods.Genetic loci recognized earlier as susceptibility loci for late-onset AD in whole genome scan at 1p36.12 and 15q21.1 encompassing HSPG2 and CYP19 genes were studied.The expressional changes in the CYP19 gene encoding an enzyme involved in estrogen metabolism, a hormone with controversial effects on AD, was studied in a mouse model of estrogen deprivation and replacement therapy.Also, the expression of seladin-1, an enzyme protective in apoptosis, was studied in AD and Lewy body dementia cases, and in an AD mouse model.A cluster of CYP19 SNPs was found to form a risk haplotype that was independent of sex, age and APOE polymorphism.The HSPG2 A allele in conjunction with APOE ε4 allele doubled the risk of AD compared to the APOE ε4 allele alone, and the tau pathology was more prominent in HSPG2 A and APOE ε4 carriers than in APOE ε4 allele carriers alone, suggesting that HSPG2 and APOE might interact at the cellular level impacting more on tau pathology rather than influencing Aβ pathology.The down-regulation of seladin-1 expression was specific for AD, and it was associated with hyperphosphorylation of tau protein.These genes associated with AD in the present studies may represent potential targets for further genetic and functional analysis in the field of AD therapeutics.
Language: Finnish
Open Access status: green
OpenAlex ID: W3095991086
Cites: 525
Cited by:
Related to: 10